MA50018A - Nouvelles utilisations d'un antagoniste du récepteur 5-ht6 pur - Google Patents

Nouvelles utilisations d'un antagoniste du récepteur 5-ht6 pur

Info

Publication number
MA50018A
MA50018A MA050018A MA50018A MA50018A MA 50018 A MA50018 A MA 50018A MA 050018 A MA050018 A MA 050018A MA 50018 A MA50018 A MA 50018A MA 50018 A MA50018 A MA 50018A
Authority
MA
Morocco
Prior art keywords
pur
new uses
receiver antagonist
antagonist
receiver
Prior art date
Application number
MA050018A
Other languages
English (en)
Inventor
Venkata Ramalingayya Grandhi
Venkateswarlu Jasti
Pradeep Jayarajan
Ramakrishna Nirogi
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of MA50018A publication Critical patent/MA50018A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA050018A 2017-07-03 2018-06-29 Nouvelles utilisations d'un antagoniste du récepteur 5-ht6 pur MA50018A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201741023375 2017-07-03

Publications (1)

Publication Number Publication Date
MA50018A true MA50018A (fr) 2020-07-08

Family

ID=63080233

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050018A MA50018A (fr) 2017-07-03 2018-06-29 Nouvelles utilisations d'un antagoniste du récepteur 5-ht6 pur

Country Status (16)

Country Link
US (1) US20210338661A1 (fr)
EP (1) EP3648765A1 (fr)
JP (1) JP6959371B2 (fr)
KR (1) KR102508303B1 (fr)
CN (1) CN110799189A (fr)
AU (1) AU2018297653C1 (fr)
BR (1) BR112019027707A2 (fr)
CA (1) CA3067929C (fr)
EA (1) EA202090127A1 (fr)
IL (1) IL271694B1 (fr)
MA (1) MA50018A (fr)
MX (1) MX2019015606A (fr)
NZ (1) NZ761037A (fr)
SG (1) SG11201913104QA (fr)
WO (1) WO2019008484A1 (fr)
ZA (1) ZA201908471B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11013564B2 (en) 2018-01-05 2021-05-25 Board Of Regents Of The University Of Nebraska Single-arm robotic device with compact joint design and related systems and methods
MX2022006535A (es) 2019-12-02 2022-09-09 Suven Life Sciences Ltd Métodos para tratar síntomas de comportamiento y psicológicos en pacientes con demencia.
CN114761008B (zh) 2019-12-02 2024-07-19 苏文生命科学有限公司 用于在患有痴呆的患者中治疗行为和心理症状的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1581492T1 (sl) 2002-11-28 2008-12-31 Suven Life Sciences Ltd N-arilsulfonil-3-substituirani indoli, ki imajo afiniteto za serotoninski receptor, postopek za njihovo pripravo in farmacevtski sestavek, ki jih vsebuje
DK1581538T3 (da) * 2002-12-18 2007-06-25 Suven Life Sciences Ltd Tetracykliske 3-substituerede indoler med serotoninreceptoraffinitet
AU2005291542B2 (en) * 2004-09-30 2010-11-04 F. Hoffmann-La Roche Ag Compositions and methods for treating cognitive disorders
MX2011010030A (es) * 2009-03-26 2011-10-11 Dainippon Sumitomo Pharma Co Medicamento novedoso para el tratamiento del deterioro cognitivo.
EP3043799A1 (fr) * 2013-09-09 2016-07-20 Sanofi Antagoniste des récepteurs h3 combiné à un inhibiteur de la cholinestérase et utilisé dans le cadre du traitement de la maladie d'alzheimer
BR112016010788B1 (pt) * 2013-12-02 2023-03-21 Suven Life Sciences Limited Processo para a produção em grande escala de monohidrato de dimesilato de 1-[(2-bromofenil)sulfonil]-5-metoxi-3-[(4-metil-1-piperazinil)metil]-1h- indola
SG11201809725TA (en) * 2016-05-18 2018-12-28 Suven Life Sciences Ltd Combination of pure 5-ht6 receptor antagonists with nmda receptor antagonist
JP6629464B2 (ja) * 2016-05-18 2020-01-15 スヴェン・ライフ・サイエンシズ・リミテッド 純粋な5−ht6受容体アンタゴニスト、アセチルコリンエステラーゼ阻害剤及びnmda受容体アンタゴニストの3種類の組合せ
MX2019003815A (es) * 2016-10-03 2019-08-12 Suven Life Sciences Ltd Composiciones farmaceuticas de antagonista del 5-ht6.

Also Published As

Publication number Publication date
US20210338661A1 (en) 2021-11-04
JP6959371B2 (ja) 2021-11-02
IL271694A (en) 2020-02-27
KR20200019747A (ko) 2020-02-24
MX2019015606A (es) 2022-09-07
NZ761037A (en) 2022-10-28
WO2019008484A1 (fr) 2019-01-10
SG11201913104QA (en) 2020-01-30
AU2018297653C1 (en) 2022-03-31
BR112019027707A2 (pt) 2020-08-11
CA3067929C (fr) 2022-09-20
CA3067929A1 (fr) 2019-01-10
EP3648765A1 (fr) 2020-05-13
JP2020525480A (ja) 2020-08-27
KR102508303B1 (ko) 2023-03-09
CN110799189A (zh) 2020-02-14
AU2018297653A1 (en) 2020-02-06
AU2018297653B2 (en) 2021-10-14
IL271694B1 (en) 2024-09-01
ZA201908471B (en) 2022-06-29
EA202090127A1 (ru) 2020-04-15

Similar Documents

Publication Publication Date Title
PL3887616T3 (pl) Węzeł rusztowania
UY4665S (es) Protector mamario ondulado
MA47494A (fr) Nouvelles utilisations d'anticorps anti-sirpg
MA46203A (fr) Utilisations d'un inhibiteur d'homologue 2 de lysyl-oxydase
MA50018A (fr) Nouvelles utilisations d'un antagoniste du récepteur 5-ht6 pur
FR3056033B1 (fr) Protection d'un reseau hvdc
CL2018000959S1 (es) Un respirador
FR3027173B1 (fr) Architecture d'un reseau de telecommunication
DK3652388T3 (da) Bygningskonstruktionssystem
DK3535461T3 (da) Sprængningsbeskyttelsesvæg
EP3867483C0 (fr) Marche auto-rétractable
FR3020136B1 (fr) Installation de surveillance d'un ouvrage
DK3596285T3 (da) Bygningsanlæg
FI11774U1 (fi) Talotikkaat
DK3453985T3 (da) Bioklimatisk bygning
DK3357682T4 (da) Bygningskonstruktion
DK3552506T3 (da) Underlivsbeklædning
MA53918A (fr) Nouvelles utilisations d'un agoniste du récepteur 5-ht4
MA45493A (fr) Inhibiteurs d'entrée de hcmv.
FR3034272B1 (fr) Reseau de communication et nœud de communication d'un reseau de communication
UA42033S (uk) Рівень будівельний
UA38534S (uk) Рівень будівельний
UA38542S (uk) Рівень будівельний
UA38235S (uk) Рівень будівельний
MA54534A (fr) Antagonistes